ISSN: 2311-3278
+44-77-2385-9429
Italy
Extended Abstract
Pharmaceutical Sciences 2018: Vandetanib in anaplastic thyroid cancer-Poupak Fallahi-University of Pisa
Author(s): Poupak Fallahi
Introduction
Thyroid cancer accounts for about 1% of all cancers1 and is the most common malignant endocrinological tumor. In the last few decades, an increased TC incidence has been shown (from 10.3 per 100,000 individuals in 2000 to 21.5 per 100,000 .. View More»